Since 1996 WHN is the second oldest medical website on the net, second only to the American Medical Association, servicing over 35,000 physicians and scientists worldwide.

Non-Profit Trusted Source of Non-Commercial Health Information

How Ozempic, Wegovy...
 
Notifications
Clear all

How Ozempic, Wegovy, and Mounjaro compare on weight loss effectiveness

2 Posts
2 Users
0 Reactions
124 Views
Posts: 1
Guest
Topic starter
(@Dr. Know)
New Member
Joined: 6 months ago

Woman trying to button her pants under her overweight belly

Note, Wegovy and Zepbound are the only two drugs approved to treat obesity in the US. Novo Nordisk’s Ozempic and Eli Lilly’s Mounjaro are approved in the US and UK for treating type 2 diabetes.

Tirzepatide, the main ingredient in both Zepbound and Mounjaro, was found in trials to achieve an average weight loss of 26% in one year. In Eli Lilly’s SURMOUNT-4 trial of 783 adults who were overweight or obese but without diabetes, random participants who took the drug for 36 weeks were switched to a placebo and at 88 weeks maintained a 9.5% weight loss from their baseline.

Ozempic, Wegovy, Mounjaro: Which is best for weight loss? (qz.com)

1 Reply
Carol Petersen
Posts: 63
Admin
(@carol-petersen)
Member
Joined: 11 months ago

These drugs are causing loss of muscle, impaired digestion, loss of bile flow and pancreatitis.   What's a good recovery protocol?

Reply

Leave a reply

Author Name

Author Email

Title *

Maximum allowed file size is 400MB

 
Preview 0 Revisions Saved